Alessandro Bertini, Stefano Facchini, Ilaria Quartesan, Riccardo Currò, Ricardo Parolin Schnekenberg, Natalia Dominik, Gustavo Alves, Lucia Ferullo, Arianna Tucci, Henry Houlden, Mary M Reilly, Andrea Cortese
{"title":"Charcot-Marie-Tooth病的CGG重复扩增:来自100,000基因组计划的见解。","authors":"Alessandro Bertini, Stefano Facchini, Ilaria Quartesan, Riccardo Currò, Ricardo Parolin Schnekenberg, Natalia Dominik, Gustavo Alves, Lucia Ferullo, Arianna Tucci, Henry Houlden, Mary M Reilly, Andrea Cortese","doi":"10.1136/jnnp-2025-336590","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>CGG expansions in <i>NOTCH2NLC</i> and <i>LRP12</i> were recently identified as a cause of Charcot-Marie-Tooth disease (CMT) in 1.2%-10.6% of genetically undiagnosed patients in China, Taiwan and Japan. However, their relevance in CMT patients of different ethnic origin is still unknown.</p><p><strong>Methods: </strong>Here, we leveraged short-read whole genome sequencing data from the 100 000 Genomes Project to investigate the presence and frequency of CGG expansions in <i>NOTCH2NLC</i>, <i>LRP12</i> and additional genes associated with oculopharyngodistal myopathy (OPDM), in 560 genetically unsolved patients diagnosed with CMT and 32 509 non-neurological controls.</p><p><strong>Results: </strong>Repeat expansions in <i>NOTCH2NLC</i>, <i>LRP12</i>, <i>RILPL1</i>, <i>NUTM2B-AS1</i> and <i>ABCD3</i> were absent from 560 genetically unsolved patients with CMT, mostly of Northern European ancestry. One patient of African ancestry carried an expanded allele in <i>GIPC1</i>, below the reported pathogenic threshold. However, rare expansions in this gene, as well as in <i>NOTCH2NLC</i>, <i>NUTM2B-AS1</i> and <i>ABCD3</i>, were also detected in controls (≤0.05%). The distribution of repeat size at these loci varied significantly across different ethnicities, with larger non-pathogenic intermediate alleles of <i>NOTCH2NLC</i> and <i>LRP12</i> typically observed in East Asians.</p><p><strong>Conclusions: </strong>CGG expansions in <i>NOTCH2NLC</i>, <i>LRP12</i> and other OPDM-associated genes do not appear to be a relevant cause of CMT in the UK. The larger size of non-pathogenic intermediate alleles of <i>NOTCH2NLC</i> and <i>LRP12</i> in East Asians could explain their ancestry-specific propensity to further expand into the full pathogenic range.</p>","PeriodicalId":16418,"journal":{"name":"Journal of Neurology, Neurosurgery, and Psychiatry","volume":" ","pages":""},"PeriodicalIF":8.7000,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"CGG repeat expansions in Charcot-Marie-Tooth disease: insights from the 100 000 Genomes Project.\",\"authors\":\"Alessandro Bertini, Stefano Facchini, Ilaria Quartesan, Riccardo Currò, Ricardo Parolin Schnekenberg, Natalia Dominik, Gustavo Alves, Lucia Ferullo, Arianna Tucci, Henry Houlden, Mary M Reilly, Andrea Cortese\",\"doi\":\"10.1136/jnnp-2025-336590\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>CGG expansions in <i>NOTCH2NLC</i> and <i>LRP12</i> were recently identified as a cause of Charcot-Marie-Tooth disease (CMT) in 1.2%-10.6% of genetically undiagnosed patients in China, Taiwan and Japan. However, their relevance in CMT patients of different ethnic origin is still unknown.</p><p><strong>Methods: </strong>Here, we leveraged short-read whole genome sequencing data from the 100 000 Genomes Project to investigate the presence and frequency of CGG expansions in <i>NOTCH2NLC</i>, <i>LRP12</i> and additional genes associated with oculopharyngodistal myopathy (OPDM), in 560 genetically unsolved patients diagnosed with CMT and 32 509 non-neurological controls.</p><p><strong>Results: </strong>Repeat expansions in <i>NOTCH2NLC</i>, <i>LRP12</i>, <i>RILPL1</i>, <i>NUTM2B-AS1</i> and <i>ABCD3</i> were absent from 560 genetically unsolved patients with CMT, mostly of Northern European ancestry. One patient of African ancestry carried an expanded allele in <i>GIPC1</i>, below the reported pathogenic threshold. However, rare expansions in this gene, as well as in <i>NOTCH2NLC</i>, <i>NUTM2B-AS1</i> and <i>ABCD3</i>, were also detected in controls (≤0.05%). The distribution of repeat size at these loci varied significantly across different ethnicities, with larger non-pathogenic intermediate alleles of <i>NOTCH2NLC</i> and <i>LRP12</i> typically observed in East Asians.</p><p><strong>Conclusions: </strong>CGG expansions in <i>NOTCH2NLC</i>, <i>LRP12</i> and other OPDM-associated genes do not appear to be a relevant cause of CMT in the UK. The larger size of non-pathogenic intermediate alleles of <i>NOTCH2NLC</i> and <i>LRP12</i> in East Asians could explain their ancestry-specific propensity to further expand into the full pathogenic range.</p>\",\"PeriodicalId\":16418,\"journal\":{\"name\":\"Journal of Neurology, Neurosurgery, and Psychiatry\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":8.7000,\"publicationDate\":\"2025-07-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Neurology, Neurosurgery, and Psychiatry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1136/jnnp-2025-336590\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Neurology, Neurosurgery, and Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/jnnp-2025-336590","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
CGG repeat expansions in Charcot-Marie-Tooth disease: insights from the 100 000 Genomes Project.
Background: CGG expansions in NOTCH2NLC and LRP12 were recently identified as a cause of Charcot-Marie-Tooth disease (CMT) in 1.2%-10.6% of genetically undiagnosed patients in China, Taiwan and Japan. However, their relevance in CMT patients of different ethnic origin is still unknown.
Methods: Here, we leveraged short-read whole genome sequencing data from the 100 000 Genomes Project to investigate the presence and frequency of CGG expansions in NOTCH2NLC, LRP12 and additional genes associated with oculopharyngodistal myopathy (OPDM), in 560 genetically unsolved patients diagnosed with CMT and 32 509 non-neurological controls.
Results: Repeat expansions in NOTCH2NLC, LRP12, RILPL1, NUTM2B-AS1 and ABCD3 were absent from 560 genetically unsolved patients with CMT, mostly of Northern European ancestry. One patient of African ancestry carried an expanded allele in GIPC1, below the reported pathogenic threshold. However, rare expansions in this gene, as well as in NOTCH2NLC, NUTM2B-AS1 and ABCD3, were also detected in controls (≤0.05%). The distribution of repeat size at these loci varied significantly across different ethnicities, with larger non-pathogenic intermediate alleles of NOTCH2NLC and LRP12 typically observed in East Asians.
Conclusions: CGG expansions in NOTCH2NLC, LRP12 and other OPDM-associated genes do not appear to be a relevant cause of CMT in the UK. The larger size of non-pathogenic intermediate alleles of NOTCH2NLC and LRP12 in East Asians could explain their ancestry-specific propensity to further expand into the full pathogenic range.
期刊介绍:
The Journal of Neurology, Neurosurgery & Psychiatry (JNNP) aspires to publish groundbreaking and cutting-edge research worldwide. Covering the entire spectrum of neurological sciences, the journal focuses on common disorders like stroke, multiple sclerosis, Parkinson’s disease, epilepsy, peripheral neuropathy, subarachnoid haemorrhage, and neuropsychiatry, while also addressing complex challenges such as ALS. With early online publication, regular podcasts, and an extensive archive collection boasting the longest half-life in clinical neuroscience journals, JNNP aims to be a trailblazer in the field.